This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Joo Young Dong: Inventor in Metabolic Health and Pharmaceutical Formulations.
Introduction
Joo Young Dong is an inventor associated with Hwaseong, South Korea, and Hanmi Pharm. Co., Ltd. His patent work includes pharmaceutical compositions and formulations involving glucagon derivatives and metabolic therapies. He is named on 2 patents.
Latest Patents
One of Dong’s listed patents, “Composition Comprising Glucagon and GLP-1 and GIP Receptor Dual Agonist and Therapeutic Use of Same,” describes a composition combining a glucagon derivative with a GLP-1 and GIP receptor dual agonist. The disclosed composition is intended for preventing or treating metabolic syndrome.
Another listed patent is “Liquid Formulation of Long-Acting Conjugate of Glucagon Derivative.” Its title indicates a focus on liquid formulations for a long-acting glucagon-derivative conjugate.
Career Highlights
Dong’s listed inventions reflect research into pharmaceutical compositions and drug formulations, particularly those related to glucagon derivatives and metabolic conditions. His work is associated with Hanmi Pharm. Co., Ltd.
Collaborations
Sung Min Bae and Hyung Kyu Lim are identified as Dong’s coworkers. The provided information does not specify their roles in the listed patents.
Conclusion
Joo Young Dong’s patent portfolio highlights pharmaceutical research involving metabolic therapies and glucagon-derivative formulations, with his listed work connected to Hanmi Pharm. Co., Ltd.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile